Patient-Reported Outcome Measures in Oncology Drugs Approved by the European Medicines Agency, 2017-2021.

JAMA Netw Open

Comprehensive Cancer Centre, Istituto di Ricovero e Cura a Carattere Scientifico-Azienda Unità Sanitaria Locale Reggio Emilia, Italy.

Published: January 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857398PMC
http://dx.doi.org/10.1001/jamanetworkopen.2022.51564DOI Listing

Publication Analysis

Top Keywords

patient-reported outcome
4
outcome measures
4
measures oncology
4
oncology drugs
4
drugs approved
4
approved european
4
european medicines
4
medicines agency
4
agency 2017-2021
4
patient-reported
1

Similar Publications

Minimally Invasive Glass-Ceramic Restorations: Clinical and Patient-Reported Outcomes in Full-Mouth Rehabilitations.

J Dent

January 2025

Clinic of Reconstructive Dentistry, Center for Dental Medicine, University of Zurich, Plattenstrasse 11, CH-8032, Zurich, Switzerland.

Objectives: To evaluate clinical outcomes (restoration survival, technical and biological complications), and patient-reported outcome measures (PROMs) of full mouth rehabilitation with minimally invasive glass-ceramic restorations after up to 12 years of clinical service.

Materials And Methods: Twenty individuals (12 females, 8 males) received full-mouth rehabilitation with minimally invasive tooth-supported glass-ceramic restorations during the years 2009 - 2017 and agreed to participate in a follow-up visit. Full dental and periodontal examinations were completed, and the restorations were evaluated according to United States Public Health Service (USPHS) criteria.

View Article and Find Full Text PDF

Characteristics of older patients undergoing major oncological surgery: Insights from the Geriatric Surgery Verification Program.

J Geriatr Oncol

January 2025

Department of Surgery, Division of Surgical Oncology, Roger Williams Medical Center, Providence, RI, United States of America; Department of Surgery, Boston University Medical Center, Boston, MA, United States of America. Electronic address:

Introduction: Studies outlining the unique burden of geriatric medical conditions and syndromes among older adults undergoing major oncological surgery are lacking, along with understanding of the goals of care for this population.

Materials And Methods: We conducted a single-institutional review of the initial 50 patients who enrolled in the American College of Surgeons' Geriatric Surgery Verification Program (GSV) program implemented for those ≥65 years undergoing major oncological surgery during the year 2023. Patient variables were categorized into four domains - somatic, functional, psychological, and social.

View Article and Find Full Text PDF

Background: Calf muscle weakness is a common symptom in slowly progressive neuromuscular disorders that lead to walking problems like instability and increased walking effort. The mainstay of treatment to improve walking in this population is the provision of ankle-foot-orthoses (AFOs). Since we are not aware of an up-to-date and complete overview of the effects of AFOs used for calf muscle weakness in slowly progressive neuromuscular disorders, we reviewed the evidence for the effectiveness of AFOs to improve walking in this patient group, in order to support clinical decision-making.

View Article and Find Full Text PDF

Background: The impact of different systemic treatments on the health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) is still unclear.

Objectives: To compare and evaluate the effects of various systemic interventions on the HRQoL in patients with mCRC.

Material And Methods: A thorough search was conducted using four electronic databases (PubMed, Embase, Scopus, and Cochrane Library) to locate relevant literature published in peer-reviewed journals.

View Article and Find Full Text PDF

Background: Atrial septal defects (ASDs) are a common cause of congenital heart disease worldwide.

Objectives: The purpose of the study was to assess change over time in surgical outcomes for ASD repair and identify patient-level risk factors for adverse postoperative outcomes.

Methods: We analyzed cases of isolated ASD in patients <18 years from 2010 to 2020 from 71 sites participating in the International Quality Improvement Collaborative for Congenital Heart Disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!